Literature DB >> 26894304

Adhesions and endometriosis: challenges in subfertility management : (An expert opinion of the ANGEL-The ANti-Adhesions in Gynaecology Expert PaneL-group).

R L De Wilde1, J Alvarez2, H Brölmann3, R Campo4, Y Cheong5, P Lundorff6, L Pawelczyk7, H Roman8, A di Spiezio Sardo9, M Wallwiener10.   

Abstract

There is molecular evidence that endometriosis has a negative impact on the ovaries, although the exact pathophysiology concerning endometriosis-associated subfertility is not known. The negative impact on the tubo-ovarian unit can be directly by distorting the anatomy, indirectly by invoking inflammation or by oxidative damage with poorer-quality oocytes. Endometriosis even seems to have a negative effect on pregnancy outcome after in vitro fertilization.

Entities:  

Keywords:  Adhesion prophylactic agents; Adhesions; Endometriosis; Subfertility management

Mesh:

Year:  2016        PMID: 26894304      PMCID: PMC4937065          DOI: 10.1007/s00404-016-4049-2

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


Endometriosis is a common, chronic and enigmatic disease. Its exact prevalence is unknown, but up to 10 % of the general female population and up to 50 % of subfertile women could be affected [1, 2]. Women complaining of infertility are six to eight times more likely to have endometriosis compared to fertile women [3]. There is molecular evidence that endometriosis has a negative impact on the ovaries [4], although the exact pathophysiology concerning endometriosis-associated subfertility is not known. The negative impact on the tubo-ovarian unit can be directly by distorting the anatomy [5], indirectly by invoking inflammation [6, 7] or by oxidative damage [8] with poorer-quality oocytes [9]. Endometriosis even seems to have a negative effect on pregnancy outcome after in vitro fertilization [10, 11]. Endometriosis, due to its inflammatory nature, is an adhesiogenic disease. Its recurrent nature means that repeated surgeries are often required, which leads to further adhesion formation [12]. For these reasons, adhesions and endometriosis are two connected entities and adhesion prevention in endometriosis treatment should be considered important [13]. The economic burden of endometriosis is heavy (0.8–12.5 billion euros per country and year in Europe) and comparable to other chronic diseases such as diabetes [14]. Endometriosis has significant negative impact on social, familial, sexual, educational and professional aspects of the daily life [14-16]. The pain, psychological and social dysfunction subsequently impairs the quality of life and decreases professional productivity [17]. As there is no clear cause or cure, the disease is likely to be chronic and recurrent. The potential impact on sexuality and fertility has a continuous negative effect on partnership. Symptomatic hormonal therapies and analgesics can be effective in endometriosis-associated pain [18], but there is no evidence that these treatments improve fertility. In fact, many of those hormone-influencing medical treatments inhibit ovulation. In clinical practice, surgical procedures such as laparoscopy are required to confirm the diagnosis and to surgically resect the lesions. This procedure can be useful in reducing pain [18] and improving fertility in stage I or II [19], even in stage III or IV [20]. Managing endometriosis requires consideration of one of the most crucial problems experienced in gynaecology today: adhesion formation. Adhesions adversely affect fertility by influencing adnexal anatomy and gamete- as well as embryo transport [21], and surgery in endometriosis is thought to be a major cause of adhesion formation. Surgically-induced adhesion formation awareness [22] and the knowledge of adhesion-reducing standards are only mainly seen by minimal-access surgeons [23]. The ESGE Adhesions Research Working Group [24] and the European Society of Human Reproduction and Embryology [25] recommend the consistent use of an anti-adhesion standard and eventually adhesion prophylactic agents during endometriosis surgery [18] on a expert opinion level base of evidence. In a society with growing health care costs and limited resources, health professionals, policy makers and insurance companies need to pay attention to the consequences of endometriosis and the role played by adhesions [26]. This knowledge should be taken into account to better assist women suffering from endometriosis and in coping with the effects of the disease on their daily lives. Because endometriosis is under-diagnosed, under-reported and under-researched, the pathophysiology itself and the concurring disease-related adhesion formation lead to fertility changes making a global future plan necessary to improve endometriosis-, adhesions- and the related subfertility outcomes.
  24 in total

Review 1.  New considerations for the pathogenesis of endometriosis.

Authors:  R Gazvani; A Templeton
Journal:  Int J Gynaecol Obstet       Date:  2002-02       Impact factor: 3.561

Review 2.  The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary.

Authors:  A M Sanchez; P Viganò; E Somigliana; P Panina-Bordignon; P Vercellini; M Candiani
Journal:  Hum Reprod Update       Date:  2013-10-14       Impact factor: 15.610

3.  Modern concepts of endometriosis. Classification and its consequences for therapy.

Authors:  R S Schenken
Journal:  J Reprod Med       Date:  1998-03       Impact factor: 0.142

Review 4.  Epidemiology of endometriosis.

Authors:  B Eskenazi; M L Warner
Journal:  Obstet Gynecol Clin North Am       Date:  1997-06       Impact factor: 2.844

Review 5.  Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis.

Authors:  Mukhri Hamdan; Siti Z Omar; Gerard Dunselman; Ying Cheong
Journal:  Obstet Gynecol       Date:  2015-01       Impact factor: 7.661

6.  Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries.

Authors:  Kelechi E Nnoaham; Lone Hummelshoj; Premila Webster; Thomas d'Hooghe; Fiorenzo de Cicco Nardone; Carlo de Cicco Nardone; Crispin Jenkinson; Stephen H Kennedy; Krina T Zondervan
Journal:  Fertil Steril       Date:  2011-06-30       Impact factor: 7.329

Review 7.  Role of cytokines in endometriosis-associated infertility.

Authors:  Tomio Iwabe; Tasuku Harada; Naoki Terakawa
Journal:  Gynecol Obstet Invest       Date:  2002       Impact factor: 2.031

8.  A European survey on awareness of post-surgical adhesions among gynaecological surgeons.

Authors:  Markus Wallwiener; Philippe Robert Koninckx; Andreas Hackethal; Hans Brölmann; Per Lundorff; Michal Mara; Arnaud Wattiez; Rudy Leon De Wilde
Journal:  Gynecol Surg       Date:  2013-11-27

9.  The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey.

Authors:  A A De Graaff; T M D'Hooghe; G A J Dunselman; C D Dirksen; L Hummelshoj; S Simoens
Journal:  Hum Reprod       Date:  2013-07-11       Impact factor: 6.918

10.  Predicting formation of adhesions after gynaecological surgery: development of a risk score.

Authors:  Per Lundorff; Hans Brölmann; Philippe Robert Koninckx; Michal Mara; Arnaud Wattiez; Markus Wallwiener; Geoffrey Trew; Alison M Crowe; Rudy Leon De Wilde
Journal:  Arch Gynecol Obstet       Date:  2015-07-30       Impact factor: 2.344

View more
  3 in total

1.  Germany Endometriosis Pattern Changes; Prevalence and Therapy over 2010 and 2019 Years: A Retrospective Cross-Sectional Study.

Authors:  Jacob Göhring; Maja Drewes; Matthias Kalder; Karel Kostev
Journal:  Int J Fertil Steril       Date:  2022-05-08

2.  Platelet-to-Lymphocyte Ratio and CA125 Level as a Combined Biomarker for Diagnosing Endometriosis and Predicting Pelvic Adhesion Severity.

Authors:  Cuishan Guo; Chiyuan Zhang
Journal:  Front Oncol       Date:  2022-06-21       Impact factor: 5.738

3.  Randomized Controlled Trial of Hyalobarrier® Versus No Hyalobarrier® on the Ovulatory Status of Women with Periovarian Adhesions: A Pilot Study.

Authors:  Ying Cheong; Sarah Bailey; Jane Forbes
Journal:  Adv Ther       Date:  2016-11-29       Impact factor: 3.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.